SkyQuest Technology Group recently introduced Molecular Diagnostics Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Molecular Diagnostics Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Molecular Diagnostics Market size was valued at USD 15.8 billion in 2023 and is poised to grow from USD 16.89 billion in 2024 to USD 28.8 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
molecular diagnostics market offers great potential for growth owing to the technological progress, development of new technologies, the growth of the number of cases of infectious diseases, and the utilization of individualized medicine. Molecular diagnostics includes detection and characterization of disease biomolecules ranging from genetic markers, proteins, and other analytes. This market is extensive, and it covers areas such as infectious diseases, oncology, genetic disorders, pharmacogenomics and many more.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/molecular-diagnostics-market
Modern progress in molecular diagnosis led to the creation of new technologies: PCR, NGS, microarray in the recent years within the molecular diagnostics market. These innovations have thus resulted in increased sensitivity of tests and specificity of the diseases they diagnose, alongside increased multiplexing capabilities thus faster and accurate diagnosis of diseases. The molecular diagnostics market is growing significantly in the market, especially with the increasing rates of infectious diseases like HIV, hepatitis, and respiratory infections. The molecular diagnostics market is currently undergoing significant growth in the worldwide market, particularly with the rising instances of infectious diseases including HIV, hepatitis, and respiratory infections. Besides, the population is aging, and the prevalence of chronic diseases such as cancer and inherited disorders is growing, which necessitates effective molecular diagnostics tests for early identification and targeted therapeutic interventions.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Molecular Diagnostics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Product
Reagents & Kits, Instruments, Services & Software
Test Type
Lab Tests, POC Tests
Sample Type
Blood, Serum, And Plasma, Urine, Other Sample Types
Technology
Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, In Situ Hybridization, DNA Microarrays, Other Technologies
Application
Infectious Disease Diagnostics (Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, Other Infectious Diseases), Oncology Testing (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Other Cancer Types), Genetic Testing, Other Applications
End User
Diagnostic Laboratories, Hospitals & Clinics, Other End Users
Molecular Diagnostics Market – Regional Analysis:
– Molecular Diagnostics North America Market includes (Canada, Mexico, USA)
– Molecular Diagnostics Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Molecular Diagnostics Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Molecular Diagnostics South America Market includes (Brazil, Argentina)
– Molecular Diagnostics Oceania Market (Australia & New Zealand)
Top Market Players in Molecular Diagnostics Market are:
F. Hoffmann-La Roche Ltd. (Switzerland)
Hologic, Inc. (US)
Abbott Laboratories (US)
Illumina, Inc. (US)
Thermo Fisher Scientific Inc. (US)
bioMerieux (France)
QIAGEN (Netherlands)
Becton Dickinson And Company (US)
Grifols S.A. (Spain)
Bio-Rad Laboratories, Inc. (US)
Sysmex Corporation (Japan)
Quidel Corporation (US)
Biocartis (Belgium)
DiaSorin (Italy)
Myriad Genetics (US)
Revvity (US)
MDxHealth (Belgium)
OncoCyte Corporation (US)
Molecular Diagnostics Key Market Trends:
Shift towards Point-of-Care Testing: There is a growing trend towards point-of-care molecular testing, driven by the need for rapid diagnosis and treatment monitoring in various healthcare settings, including clinics, emergency rooms, and ambulances. Miniaturized and portable molecular diagnostic devices are being developed to enable real-time testing outside traditional laboratory settings, enhancing patient care and healthcare efficiency.
Integration of Artificial Intelligence (AI) and Big Data Analytics: The integration of AI and big data analytics in molecular diagnostics is revolutionizing data interpretation, enabling more accurate and personalized diagnosis and treatment strategies. Machine learning algorithms can analyze vast amounts of genomic data to identify disease patterns, predict treatment responses, and optimize therapeutic outcomes. This trend is expected to accelerate the adoption of molecular diagnostics in precision medicine and improve patient outcomes.
Also Read –
https://www.openpr.com/news/3948314/medical-aesthetics-market-industry-growth-blueprint-and-future
https://www.newstrail.com/geosynthetics-market-is-set-to-experience-a-revolutionary-growth-2025-2032/
Forward-Looking Insights
The Molecular Diagnostics Market is set to experience sustained growth, fueled by technological advancements, broader market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
